This content requires a premium subscription.
Please log in or subscribe to continue.
JACC Specialty Journals
JACC: CardioOncology Pulse - The PROACT Trial: Findings and Key Takeaways
Released: Apr 16, 2024
JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority trial of enalapril to prevent anthracycline induced cardiotoxicity.
JACC: CardioOncology Pulse - The PROACT Trial: Findings and Key Takeaways